11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Obesity, diabetes, and metabolic syndrome result from complex interactions between genetic and environmental factors, including the gut microbiota. To dissect these interactions, we utilized three commonly used inbred strains of mice-obesity/diabetes-prone C57Bl/6J mice, obesity/diabetes-resistant 129S1/SvImJ from Jackson Laboratory, and obesity-prone but diabetes-resistant 129S6/SvEvTac from Taconic-plus three derivative lines generated by breeding these strains in a new, common environment. Analysis of metabolic parameters and gut microbiota in all strains and their environmentally normalized derivatives revealed strong interactions between microbiota, diet, breeding site, and metabolic phenotype. Strain-dependent and strain-independent correlations were found between specific microbiota and phenotypes, some of which could be transferred to germ-free recipient animals by fecal transplantation. Environmental reprogramming of microbiota resulted in 129S6/SvEvTac becoming obesity resistant. Thus, development of obesity/metabolic syndrome is the result of interactions between gut microbiota, host genetics, and diet. In permissive genetic backgrounds, environmental reprograming of microbiota can ameliorate development of metabolic syndrome.

          Related collections

          Author and article information

          Journal
          Cell Metab.
          Cell metabolism
          1932-7420
          1550-4131
          Sep 1 2015
          : 22
          : 3
          Affiliations
          [1 ] Joslin Diabetes Center and Harvard Medical School, Boston, MA 02215, USA; Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Center Munich, Munich 85764, Germany.
          [2 ] Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63108, USA; Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St. Louis, MO 63108, USA.
          [3 ] Joslin Diabetes Center and Harvard Medical School, Boston, MA 02215, USA.
          [4 ] Center for Clinical and Translational Metagenomics, Department of Pathology, Brigham and Women's Hospital Harvard Medical School, Boston, MA 021115, USA.
          [5 ] Joslin Diabetes Center and Harvard Medical School, Boston, MA 02215, USA. Electronic address: c.ronald.kahn@joslin.harvard.edu.
          Article
          S1550-4131(15)00336-8 NIHMS717513
          10.1016/j.cmet.2015.07.007
          26299453
          cd232f60-7807-4e70-8e0d-f4b5263f87b9
          Copyright © 2015 Elsevier Inc. All rights reserved.
          History

          Comments

          Comment on this article